Effects of bariatric and metabolic surgical procedures on dyslipidemia: a retrospective, observational analysis

Abstract

Aim: Obesity and co-existing metabolic comorbidities are associated with increased cardiovascular (CV) morbidity and mortality risks, generally clustered to risk factors such as dyslipidemia. The aim of this study was to evaluate the lipid profile changes in subjects with severe obesity undergoing different procedures of bariatric and metabolic surgery (BMS), sleeve gastrectomy (SG), and Roux-en-Y gastric bypass (RYGB) in a real-world, clinical setting.

Methods: A single-center, retrospective, observational clinical study was performed enrolling patients undergoing BMS. The primary outcome was the change in total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL) cholesterol, and triglycerides.

Results: In total, 123 patients were enrolled (males 25.2% and females 74.8%) with a mean age of 48.2 ± 7.9 years and a mean BMI of 47.0 ± 9.1 kg/m². All patients were evaluated until 16.9 ± 8.1 months after surgery. Total and HDL cholesterol did not change after surgery, while a significant reduction in triglyceride levels was recorded. Moreover, a rapid decline of both LDL and non-HDL cholesterol among follow-up visits was observed. In particular, significant inverse correlations were found between total cholesterol, LDL cholesterol, non-HDL cholesterol, and triglycerides and the number of months elapsed after bariatric surgery. Similarly, a direct correlation was found considering HDL cholesterol. Moreover, total cholesterol, LDL cholesterol, non-HDL cholesterol, and triglycerides significantly changed among visits after RYGB, while no changes were observed in the SG group. Finally, considering lipid-lowering therapies, the improvement in lipid asset was detected only in non-treated patients.

Conclusion: This study corroborates the knowledge of the improvement in lipid profile with BMS in clinical practice. Together with sustained weight loss, the BMS approach efficiently corrects dyslipidemia, contributing to decreasing the CV risk.

Keywords

Severe obesity / bariatric and metabolic surgery / lipid-lipoprotein profile / dyslipidemia

References

[1] Abarca-gómez L,Hamid ZA.Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults.The Lancet2017;390:2627-42 PMCID:PMC5735219

[2] Flegal KM,Orpana H.Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.JAMA2013;309:71-82 PMCID:PMC4855514

[3] Kitahara CM,Berrington de Gonzalez A.Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies.PLoS Med2014;11:e1001673 PMCID:PMC4087039

[4] Nguyen NT,Wooldridge JB,Lane JS.Association of obesity with risk of coronary heart disease: findings from the national health and nutrition examination survey, 1999-2006.Surg Obes Relat Dis2010;6:465-9

[5] Maki KC,Kirkpatrick CF.Saturated fats and cardiovascular health: Current evidence and controversies.J Clin Lipidol2021;15:765-72

[6] Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA. Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors.Diabetes Metab Res Rev2022;38:e3502

[7] Howard BV,Robbins DC.Obesity and dyslipidemia.Endocrinol Metab Clin North Am2003;32:855-67

[8] Poirier P,Mazzone T.American Heart Association Obesity Committee of the Council on NutritionPhysical Activityand MetabolismBariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association.Circulation2011;123:1683-701

[9] Buchwald H,Braunwald E.Bariatric surgery: a systematic review and meta-analysis.JAMA2004;292:1724-37

[10] Steinbrook R.Surgery for severe obesity.N Engl J Med2004;350:1075-9

[11] Melissas J,Tzikoulis V.Sleeve gastrectomy vs Roux-en-Y Gastric bypass. Data from ifso-european chapter center of excellence program.Obes Surg2017;27:847-55

[12] Rubino F.From bariatric to metabolic surgery: definition of a new discipline and implications for clinical practice.Curr Atheroscler Rep2013;15:369

[13] Lefere S,Vanlander A,Devisscher L.Bariatric surgery and the liver-mechanisms, benefits, and risks.Obes Rev2021;22:e13294

[14] Tricò D,Berta R.Effects of low-carbohydrate versus mediterranean diets on weight loss, glucose metabolism, insulin kinetics and β-cell function in morbidly obese individuals.Nutrients2021;13:1345 PMCID:PMC8074206

[15] Rubino F.Surgery: the coming of age of metabolic surgery.Nat Rev Endocrinol2012;8:702-4

[16] Bays HE,Kris-Etherton PM.Obesity, adiposity, and dyslipidemia: a consensus statement from the national lipid association.J Clin Lipidol2013;7:304-83

[17] Treatment Trialists' (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.The Lancet2012;380:581-90

[18] Piché MÈ,Harvey J,Poirier P.How to choose and use bariatric surgery in 2015.Can J Cardiol2015;31:153-66

[19] Sjöström L,Peltonen M.Swedish Obese Subjects Study Scientific GroupLifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.N Engl J Med2004;351:2683-93

[20] Piché ME,Auclair A.Effects of bariatric surgery on lipid-lipoprotein profile.Metabolism2021;115:154441

[21] Buchwald H,Boen JR.Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias.Arch Intern Med1998;158:1253-61

[22] Zlabek JA,Larson CJ,Lambert PJ.The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients.Surg Obes Relat Dis2005;1:537-42

[23] Ricci C,Rausa E,Bandera F.Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia: a meta-analysis and meta-regression study with 5-year follow-up.Obes Surg2015;25:397-405

[24] Chang SH,Song J,Eagon CJ.The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012.JAMA Surg2014;149:275-87 PMCID:PMC3962512

[25] Brethauer SA,el Chaar M.ASMBS Clinical Issues CommitteeStandardized outcomes reporting in metabolic and bariatric surgery.Surg Obes Relat Dis2015;11:489-506

[26] Friedewald WT,Fredrickson DS.Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.Clin Chem1972;18:499-502

[27] Chen G,Peng BQ,Du X.Roux-En-Y gastric bypass versus sleeve gastrectomy plus procedures for treatment of morbid obesity: systematic review and meta-analysis.Obes Surg2021;31:3303-11

[28] Pérez-Arana GM,Camacho-Ramírez A.Sleeve gastrectomy and Roux-En-Y gastric bypass. Two sculptors of the pancreatic islet.J Clin Med2021;10:4217 PMCID:PMC8465472

[29] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation2002;106:3143-3421

[30] Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).JAMA2001;285:2486-97

[31] Force Members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.Atherosclerosis2019;290:140-205

[32] Piché ME,Hodson L.Relevance of human fat distribution on lipid and lipoprotein metabolism and cardiovascular disease risk.Curr Opin Lipidol2018;29:285-92

[33] Björnson E,Taskinen MR.Kinetics of plasma triglycerides in abdominal obesity.Curr Opin Lipidol2017;28:11-8

[34] McQuaid SE,Neville MJ.Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?.Diabetes2011;60:47-55 PMCID:PMC3012196

[35] Lewis GF.Fatty acid regulation of very low density lipoprotein production.Curr Opin Lipidol1997;8:146-53

[36] Hodson L.Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state.Proc Nutr Soc2019;78:126-34

[37] Zhang C,Zhou Z.Changes in fasting bile acid profiles after Roux-en-Y gastric bypass and sleeve gastrectomy.Medicine (Baltimore)2021;100:e23939 PMCID:PMC7837931

[38] Xu G.Recent advances in the mechanisms underlying the beneficial effects of bariatric and metabolic surgery.Surg Obes Relat Dis2021;17:231-8 PMCID:PMC7769897

[39] Puzziferri N,Mayo HG,Belle SH.Long-term follow-up after bariatric surgery: a systematic review.JAMA2014;312:934-42 PMCID:PMC4409000

[40] Courcoulas AP,Belle SH.Longitudinal Assessment of Bariatric Surgery (LABS) ConsortiumWeight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity.JAMA2013;310:2416-25 PMCID:PMC3955952

[41] Mauvais-jarvis F,Barnes PJ.Sex and gender: modifiers of health, disease, and medicine.The Lancet2020;396:565-82 PMCID:PMC7440877

[42] Hasan B,Alzuabi M.Weight loss and serum lipids in overweight and obese adults: a systematic review and meta-analysis.J Clin Endocrinol Metab2020;105:3695-703

[43] Resnic FS,Marinac-Dabic D.Bariatric surgery or intensive medical therapy for diabetes after 5 years.N Engl J Med2017;376:526-35

[44] Daniels P,Brusseau TA.Effect of a randomised 12-week resistance training programme on muscular strength, cross-sectional area and muscle quality in women having undergone Roux-en-Y gastric bypass.J Sports Sci2018;36:529-35

[45] Santi D,Granata ARM.Real-world evidence analysis of the follicle-stimulating hormone use in male idiopathic infertility.Best Pract Res Clin Obstet Gynaecol2022;S1521-6934(22)00068